Literature DB >> 10676029

[Treatment of hemorrhoids with the Longo technique. Preliminary results of a prospective study on 94 cases].

M Papillon1, J P Arnaud, B Descottes, J F Gravie, X Huten, N De Manzini.   

Abstract

AIM OF STUDY: The aim of this multicenter prospective study was to report the early results of Longo procedure for the surgical treatment of hemorrhoids disease. PATIENTS AND
METHOD: From April 1998 to July 1998, 94 patients (60 men and 34 women with a mean age of 47 years) were treated according to Longo procedure for a mucosal prolapse (12 grade II, 63 grade III, and 19 grade IV). All patients were evaluated at 2 and 6 postoperative months. The technique consisted in the reduction of mucosal and hemorrhoidal prolapses with a circular suturing device.
RESULTS: Postoperative morbidity rate was 6.3% (n = 6). A rectal bleeding occurred within 12 hours after surgery in five patients. The mean postoperative length of hospital stay was 36 hours (range: 24-72 hours). The only antalgic prescribed was paracetamol. Local care was not necessary in any patient. After 6 months, 89 patients (94.7%) were very satisfied, three patients (3.2%) were satisfied (rectal sub-mucosal abscess in one case, functional troubles in two cases) and two patients (2.1%) were not satisfied (persistence of mucosal prolapse).
CONCLUSION: These preliminary results are satisfactory but need to be confirmed by a prospective randomized trial, comparing Milligan Morgan procedure and Longo procedure.

Entities:  

Mesh:

Year:  1999        PMID: 10676029     DOI: 10.1016/s0001-4001(99)00079-3

Source DB:  PubMed          Journal:  Chirurgie        ISSN: 0001-4001


  1 in total

1.  Stapled hemorrhoidopexy versus milligan-morgan hemorrhoidectomy: a prospective, randomized, multicenter trial with 2-year postoperative follow up.

Authors:  Jean François Gravié; Paul-Antoine Lehur; Noël Huten; Marc Papillon; Michel Fantoli; Bernard Descottes; Patrick Pessaux; Jean-Pierre Arnaud
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.